Login to Your Account



Other News To Note


Tuesday, January 10, 2012
• Apricus Biosciences Inc., of San Diego, entered a licensing agreement granting Abbott, of Abbott Park, Ill., the exclusive rights to market Vitaros (alprostadil), Apricus Bio's treatment for erectile dysfunction, in Canada. Abbott will commercialize and market Vitaros in Canada where the drug was approved by Health Canada in late 2010, with launch anticipated in 2012.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription